Winchester, MA, United States of America

James Ahern

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Biogen Idec Ma Inc.. Active years: 2012-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Ahern. Retrieved from https://idiyas.com/inventor/james-ahern-c8q4xg5z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by James Ahern

Introduction

James Ahern is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of pharmaceutical preparations, particularly in the detection and quantitation of cyclodextrins. With a total of 2 patents to his name, Ahern's work has implications for both research and practical applications in the industry.

Latest Patents

Ahern's latest patents focus on the detection and quantitation of cyclodextrins and cyclodextrin derivatives in solutions that contain proteins. These inventions provide methods for evaluating pharmaceutical preparations for the presence of residual cyclodextrins, which is crucial for ensuring the safety and efficacy of drug formulations.

Career Highlights

James Ahern is currently associated with Biogen Idec MA Inc., where he continues to innovate and contribute to advancements in pharmaceutical sciences. His expertise in cyclodextrins has positioned him as a valuable asset in his field.

Collaborations

Ahern has collaborated with notable colleagues such as Zoran Sosic and Rulin Qian. These partnerships have likely enhanced the scope and impact of his research and inventions.

Conclusion

James Ahern's work in the detection and quantitation of cyclodextrins represents a significant advancement in pharmaceutical research. His contributions continue to influence the industry and improve drug safety and efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…